Clinical Trial Update: A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer [Phase 4]

View source ↗

Summary

This release describes a Phase 4, multicenter exploratory trial evaluating consolidation therapy with tislelizumab in combination with nintedanib for limited-st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• OFEV (Nintedanib)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Limited-stage Small Cell Lung Cancer (LS-SCLC) | Phase 4 | Status: NOT_YET_RECRUITING